Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2024 Jul 24.
Published in final edited form as: Int J Cancer. 2018 Oct 26;144(1):26–33. doi: 10.1002/ijc.31635

The association between birth order and childhood leukemia is modified by paternal age and birth weight. Pooled results from the International Childhood Cancer Cohort Consortium (I4C)

Ora Paltiel 1, Stanley Lemeshow 2, Gary S Phillips 3, Gabriella Tikellis 4, Martha S Linet 5, Anne-Louise Ponsonby 6, Per Magnus 7, Siri E Håberg 8, Sjurdur F Olsen 9, Charlotta Granström 10, Mark Klebanoff 11, Jean Golding 12, Zdenko Herceg 13, Akram Ghantous 14, Jane Elizabeth Hirst 15, Arndt Borkhardt 16, Mary H Ward 17, Signe Holst Søegaard 18, Terence Dwyer 19
PMCID: PMC11268895  NIHMSID: NIHMS1989728  PMID: 30098208

Abstract

The “delayed infection hypothesis” states that a paucity of infections in early childhood may lead to higher risks of childhood leukemia (CL), especially acute lymphoblastic leukemia (ALL).

Using prospectively collected data from six population-based birth cohorts we studied the association between birth order (a proxy for pathogen exposure) and CL. We explored whether other birth or parental characteristics modify this association.

With 2.2X106 person-years of follow-up, 185 CL and 136 ALL cases were ascertained. In Cox proportional hazards models, increasing birth order (continuous) was inversely associated with CL and ALL; hazard ratios (HR) = 0.88, 95% confidence interval (CI): (0.77– 0.99) and 0.85: (0.73–0.99), respectively. Being later-born was associated with similarly reduced hazards of CL and ALL compared to being first-born; HRs=0.78: 95% CI: 0.58–1.05 and 0.73: 0.52–1.03, respectively. Successive birth orders were associated with decreased CL and ALL risks (P for trend 0.047 and 0.055, respectively). Multivariable adjustment somewhat attenuated the associations. We found statistically significant and borderline interactions between birth weight (P=0.024) and paternal age (P=0.067), respectively, in associations between being later-born and CL, with the lowest risk observed for children born at <3 kg with fathers aged 35+ (HR=0.18, 95% CI: 0.06–0.50). This study strengthens the theory that increasing birth order confers protection against CL and ALL risks,but suggests that this association may be modified among subsets of children with different characteristics, notably advanced paternal age and lower birth weight. It is unclear whether these findings can be explained solely by infectious exposures.

Keywords: childhood leukemia, acute lymphoblastic leukemia, birth order, paternal age, birth weight, cohort studies

Introduction

Childhood leukemia is thought to be related to environmental exposures during the prenatal, postnatal, and possibly the preconception periods. Current theories on the etiology of childhood leukemia, especially acute lymphoblastic leukemia (ALL), include the “delayed infection hypothesis”, which states that reduced exposure to infection in early childhood results in an abnormal response to common pathogens, leading to lymphoproliferation and clonal expansion of B or T cell clones1. There is limited direct evidence for reduced exposure to specific infections among children who develop leukemia2 as early childhood exposure to multiple pathogens is difficult to measure precisely, particularly in retrospective studies relying on maternal recall. Therefore, proxy measures have been evaluated, including daycare attendance, breastfeeding, vaccination history, hospitalization or prescriptions for infection, as well as birth order or sibship size35among others. In fact, later-born children have increased serological evidence of several common infections6.

The association between family size and childhood cancer was first raised in 1962 by MacMahon and Newill, who showed a monotonic decrease in childhood cancer mortality for birth order 1–57. Since then, studies from many countries have explored the relationship between birth order and childhood cancer in general or leukemia in particular, with inconsistent results3,810among others. These inconsistencies may be due to differences in study design or heterogeneity regarding sociodemographic or perinatal characteristics among populations studied.

International data demonstrate secular trends of increasing birth weight11, increasing average paternal age12 as well as decreased total fertility rates and family size13. The current and future effects of these recent developments on childhood leukemia risk have received little attention. Birth weight has emerged as a clear and consistent risk factor for childhood leukemia14. Furthermore, increased paternal age has been raised as a potential risk factor for childhood ALL15. In most epidemiologic studies, these two factors have been considered as potential confounders of the association between birth order and leukemia, but have not been assessed as modifiers of this relationship. The search for modifiers may uncover specific subgroups in which biological or environmental determinants have differential impacts; this knowledge may enhance the investigation of the etiologic pathways leading to childhood leukemia.

Since childhood cancers are rare and risk factors assessed to date explain only a small part of their etiology, large collaborative efforts are required to accumulate sufficient cases for epidemiologic studies. Most epidemiologic evidence for the etiology of childhood cancer is based on retrospective studies or birth registries. The International Childhood Cancer Cohort Consortium (I4C) includes birth cohorts spanning four continents and 50 years of data collection16, each cohort providing rich and detailed perinatal and postnatal data (see supplemental data). This study aims to explore the association between birth order and childhood leukemia in the I4C and to determine whether other etiologic factors, such as birth weight, paternal age, child sex and age at diagnosis modify the effect of birth order on childhood leukemia risk.

Methods

Study population:

We pooled data from six I4C-member population-based birth cohorts (Table 1 and supplemental data), ALSPAC, CPP, DNBC, JPS, MoBa and TIHS, as detailed in our previous work on birth weight16. All childhood leukemia cases ascertained to date from participating cohorts were included in the analysis. Regarding non-cases, for four of the cohorts all children were included, while for Scandinavian cohorts, MoBa and DNBC, a random 10% sample of non-cases contributed person-time (due to cohort data-sharing policies). Children with Down syndrome and non-singleton births were excluded.

Table 1-.

Participating cohorts,* baseline characteristics1 and incident childhood cancer cases.

ALSPAC CPP4 DNBC3 JPS MoBa3 TIHS Total
Recruitment years 1991–1992 1959–1966 1996–2003 1964–1976 1999–2009 1987–1995 1959–2009
Total number of live births in cohort 14,062 58,000 96,860 92,408 108,487 10,628 380,445 (180,549 included in analysis)
Years follow-up, mean
(range)
14.9
(0.5–15)
5.6
(0.0–8.0)
14.0
(11.6–15.0)
15.0
(15–15)
9.5
(5.6–15.0)
14.7
(12.7–15.0)
12.3
(0–15)
Person-years 204,819 322,414 129,370 1,317,498 98,986 137,514 2,210,600
% Later born 56.2 71.6 67.5 70.8 55.2 53.1 68.0
Mean sibship size [SD] (range) 0.8 [1.0]
(0 – 13)
2.0
[2.1]
(0 – 21)
0.9
[0.8]
(0 – 6)
2.0
[2.3]
(0 – 16)
0.8
[0.9]
(0 – 4)
N/A 1.8
[2.1]
(0 – 21)
% Male 51.6 50.7 51.0 51.5 50.2 71.3 52.2
Mean birth weight [SD] 3,410
[551]
3,177
[531]
3,586
[567]
3,272
[523]
3,604
[561]
3,195
[751]
3,288
[560]
Mean Paternal Age at Birth [SD](range) 30.7 [5.8]
(15 – 65)
28.3 [7.0]
(14 – 66)
32.7 [5.2]
(18 – 64)
31.6 [6.8]
(16 – 80)
32.7 [5.3]
(19 – 50)
26.5 [5.6]
(14 – 63)
30.6 [6.8]
(14 – 80)
Mean Maternal Age at Birth
[SD] (range)
28.0 [5.0]
(15 – 44)
24.1 [5.9]
(12 – 48)
30.5 [4.3]
(18 – 47)
27.6 [5.7]
(13 – 59)
30.2 [4.6]
(16 – 47)
23.6 [4.4]
(13 – 45)
26.8 [5.9]
(12 – 59)
% Maternal secondary education 35.32 41.4 65.5 42.4 79.7 18.1 43.2
Total number of cancer cases
22 49 190 168 190 24 643
Leukemia 3 16 61 39 62 4 185
ALL 3 11 44 27 49 2 136
U=unknown
*

Reference describing each cohort can be found in Supporting Information A. ALL = Acute lymphoblastic leukemia; SD = Standard Deviation; N/A = Not available.

1.

Proportion with missing values shown in Supporting Information Table S1.

2.

Proportion staying in secondary education after compulsory school-leaving age.

3.

Follow-up not complete to age 15; 10% sample of “noncases” included in analysis.

4.

Follow-up for cancer to age 8 only.

Outcome assessment:

Cancer was ascertained using national or regional cancer registries, where available, or by clinical follow-up as previously described16.We calculated time to leukemia onset from birth to date of first cancer diagnosis, censoring at date of last follow-up (or age 15 years) or date of death for non-cases (see table 1). The dependent variables were all leukemia and acute lymphoblastic leukemia (ALL), in particular, as ascertained using ICD-0-3 morphology codes 9800-9946 and 9820-9837, respectively. Sample sizes were insufficient to assess other subtypes.

Exposure Assessment:

Using data recorded at baseline in the cohorts, the main independent variable was birth order analyzed as three metrics: later-born vs. first-born (dichotomous); continuous; and ordinal categories. Due to outliers in family size, we performed a sensitivity analysis curtailing continuous birth order at ≤6. Previous multiple births were counted as the number of resultant live births. Previous stillbirths were included as previous births. Paternal age and birth weight were modeled as continuous variables and, in separate analyses, as categorical variables.

The covariates assessed included sex of child, year of birth, gestational age, and birth weight, in addition to parental ages, age difference (father’s age minus mother’s age), maternal smoking and maternal education. Criteria for covariate entry into the models were their importance in the literature or change in the birth-order-cancer or birth-order-leukemia hazard ratios (HR) by more than 10% in either direction. Covariates with missing data were imputed using a chained multiple [N = 20] imputation procedure. The final set of covariates for the full dataset included birth weight (continuous), sex of the child, maternal secondary education (yes vs. no), maternal age (continuous), and paternal age (continuous). Since only 23.2% of the children in the JPS had information on gestational age, an additional analysis was performed for the subcohort with information on this covariate.

Statistical analysis:

Analysis was performed using Cox proportional hazards models, stratified by cohort. We examined whether there was heterogeneity of the association between leukemia and birth order by cohort, and found none. The pooled associations between birth order and leukemia are expressed as hazard ratios (HR) and their corresponding 95% confidence intervals (95% CI). For all analyses, P ≤ 0.05 was considered statistically significant. After testing the main-effects of birth order, we looked for first-order interactions between birth order*paternal age, and birth order*birth weight, and birth order*child sex on their relationship with leukemia and ALL, respectively. We explored the relation between birth order and leukemia diagnosed at successive ages.

Proportional hazards assumptions were confirmed using a test of the Schoenfeld residuals and by graphically observing that the transformed survival probabilities plotted over the natural log of the analysis time for both later-born and first-born were roughly parallel.

Power:

A sample size of 185 cases of leukemia was sufficient to detect a hazard ratio of 0.645 for later-born vs. first-born, with alpha=0.05 and power of 80%, assuming that two-thirds of children would be later-born.

Results

A total of 180,549 children were followed from birth until first cancer diagnosis, death, or end of follow-up. This resulted in a total of 2,210,600 person-years of follow-up and 643 incident cases of childhood cancer, of which 185 were leukemias and 136 were ALL. Years of recruitment and baseline parameters for the cohorts are shown in Table 1. We note differences in characteristics and contribution of cases depending on the size and the age of the cohort. In particular, the Scandinavian cohorts were characterized by later recruitment periods, older paternal age at birth, higher birth weights and higher number of incident cancer cases compared to the earlier cohorts; TIHS was predominantly male, with lowest mean parental ages.

Table 2 shows the unadjusted and multivariable-adjusted relationships between leukemia and birth order using the various metrics. Increasing birth order (continuous) was associated with a decreased risk of leukemia as well as ALL. The results for leukemia and ALL were especially marked after truncating birth order to ≤6 (adjusted HR 0.81 and 0.78, respectively, P=0.017).

Table 2:

Hazard ratios for childhood leukemia, and acute lymphoblastic leukemia (ALL) by birth order as a continuous, dichotomous or ordinal variable.

Cancer Type Number of cases Unadjusted Hazard ratio 95% Confidence Interval P-value Adjusted Hazard ratio 95% Confidence Interval P-value
Continuous birth order (N = 180,549) #
Leukemia 185 0.88 0.77 – 0.99 0.037 0.88 0.76 – 1.02 0.091
ALL 136 0.85 0.73 – 0.99 0.038 0.84 0.70 – 1.01 0.067
Continuous birth order truncated at ≤ 6 (N = 170,894)
Leukemia 177 0.82 0.70 – 0.95 0.009 0.81 0.68 – 0.96 0.017
ALL 131 0.80 0.66 – 0.95 0.013 0.78 0.63 – 0.96 0.017
Later born vs. first born where first born is the referent group (N = 180,549)
Leukemia 185 0.78 0.58 – 1.05 0.097 0.80 0.58 – 1.11 0.180
ALL 136 0.73 0.52 – 1.03 0.077 0.74 0.51 – 1.09 0.129
Successive birth order (N = 180,549)
Leukemia
1
2
3
≥ 4
185
79
68
22
16

1.00
0.86
0.62
0.60

---
0.61 – 1.19
0.38 – 1.02
0.33 – 1.07

---
0.357
0.058
0.082*

1.00
0.84
0.61
0.61

---
0.59 – 1.18
0.36 – 1.04
0.31 – 1.20

---
0.309
0.068
0.152
ALL
1
2
3
≥ 4
136
60
53
12
11

1.00
0.87
0.46
0.61

---
0.60 – 1.27
0.24 – 0.87
0.31 – 1.20

---
0.481
0.016
0.154*

1.00
0.85
0.44
0.59

---
0.57 – 1.26
0.23 – 0.87
0.27 – 1.31

---
0.407
0.018
0.197

The hazard ratio is adjusted for birth weight (continuous), sex of the child, maternal secondary education (yes vs. no), maternal age (continuous) and paternal age (continuous)

#

For TIHS cohort birth order beyond first-born was imputed.

*

P for trend = 0.047 and 0.055 for leukemia and ALL, respectively

Examining later-born vs. first-born we noted a borderline significant inverse relation for leukemia and ALL after adjusting for covariates. Successive birth order was associated with decreased leukemia and ALL risk (P for linear trend 0.047 and 0.055, respectively in unadjusted analyses), Table 2 and supplementary Figure 1. The association was attenuated slightly in the subcohort with available gestational age (Supplemental figure 2). The peak inverse effect of birth order on leukemia (HR = 0.62. 95% CI: 0.38–1.02) and ALL (HR = 0.46, 95% CI: 0.24 – 0.87) was particularly noted at birth order 3. Adjustment for parental age, maternal education, birth weight and child sex did not materially change the HRs but slightly affected the precision of the findings (Table 2 and Supplemental Figure 1).

A statistically significant interaction was found between birth order and continuous birth weight (P=0.024), and a borderline interaction between birth order and continuous paternal age (P=0.067), in their association with time to leukemia. In a model containing main effects of birth order as well as interactions between later-born and continuous paternal age and between later-born and continuous birth weight, the interaction P-values were 0.033 and 0.015, respectively (Supplementary Table 2).

In order to evaluate these interactions further, we conducted a stratified analysis. We examined the effect of birth order in strata of birth weight and paternal age categories individually, with a further analysis combining strata of both these variables (Table 3). In these analyses, we observe that the effect of birth order was strongest among children with lower birth weight (<3kg), in those with older fathers (≥30 years old), and the strongest inverse relations (HR = 0.26 and 0.18) was seen in children with birth weights <3 kg with older fathers (aged 30–35 and >35 years, respectively). This pattern of effect modification was unchanged after adjusting for covariates. We did not find any evidence of a time-varying relationship between birth order and age at diagnosis, using cut-offs of 1, 2, 3, 4, or 5 years of age, nor of effect modification by child’s sex (not shown).

Table 3:

Unadjusted hazard ratios and 95% confidence interval (CI) for leukemia association with birth order (later-born vs. first-born [reference category]) stratified by paternal age and birth weight categories.

Paternal age, years Birth weight, kg Observations N Leukemia N Hazard ratio for later-born vs first-born 95% CI P-value
Stratified by paternal age
≤ 25 36,628 20 0.91 0.37 – 2.25 0.833
25–30 49,585 68 1.15 0.71 – 1.87 0.560
30–35 38,507 49 0.70 0.39 – 1.25 0.226
> 35 36,881 41 0.49 0.26 – 0.96 0.037
Stratified by birth weight
< 3.0 49,539 26 0.31 0.14–0.72 0.006
3.0-<4.0 115,545 199 0.83 0.57–1.26 0.316
≥ 4.0 14,733 40 0.97 0.48–1.94 0.922
Stratified by both paternal age and birth weight
≤ 25 < 3.0 11,755 6 0.39 0.12–1.23 0.109
3.0-<4.0 22,780 10 1.08 0.43–2.74 0.870
≥ 4.0 1,991 4 1.31 0.42–4.06 0.639
25–30 < 3.0 13,233 11 0.44 0.18–1.11 0.082
3.0-<4.0 32,443 43 1.23 0.72–2.08 0.449
≥ 4.0 3,719 14 1.49 0.67–3.29 0.326
30–35 < 3.0 8,995 4 0.26 0.10–0.70 0.008
3.0-<4.0 25,521 30 0.73 0.39–1.35 0.311
≥ 4.0 3,841 15 0.88 0.38–2.04 0.766
> 35 < 3.0 8,451 4 0.18 0.06–0.50 0.001
3.0-<4.0 24,054 31 0.50 0.25–1.00 0.051
≥ 4.0 4,234 6 0.61 0.25–1.50 0.280

Discussion

In this pooled analysis of six cohort studies spanning the globe and over 40 years of recruitment, we found a clear inverse relation between childhood leukemia (and ALL) and birth order. Being a later-born child conferred a reduction in childhood leukemia risk that did not appear to be confounded by parental age, maternal education, child’s sex or birth weight. The relation did not vary by age at diagnosis. The pattern of decreased ALL risk with increasing birth order is similar to those reported in a pooled analysis from five US states8. Being a later-born rather than a first-born child implies increased early opportunities for exposure to pathogens post-partum. In general, these findings support the delayed infection hypothesis, although it is important to note that later-born children also have a different immunologic intrauterine milieu than first-borns, with evidence of differences in T-cell programming17. There may also be other environmental and biological exposures associated with birth order, such as fetal microchimerism.

Marcotte et al3 reported that birth order effects were modified by ethnicity. A novel finding in this study is the apparent modifying effect of increasing paternal age on the relation between birth order and childhood leukemia and a strong modifying effect of birth weight. Although based on small numbers, it appears that the “protective” effect of having siblings is most pronounced in children of lower birth weight and those with older fathers.

Older paternal age is associated with a variety of offspring outcomes including single gene and chromosomal abnormalities, complex disorders such as autism, schizophrenia, and type I diabetes and low birth weight18. Oksuzyan et al19 reported a significant association between paternal age (odds ratio 1.23) and childhood ALL in offspring of fathers aged 35–45 compared with fathers aged <25 years, however, no analysis of interactions was reported. Yip et al also reported an increased risk of leukemia, specifically ALL, among older fathers20.

Older fathers, besides the obvious fact that they are likely to have more offspring, more experience in childrearing, and higher incomes than younger fathers, may also bear a higher lifetime burden of environmental exposures along with higher risk of germ cell spontaneous mutations. These factors should seemingly increase the child’s leukemia risk, not the converse. Furthermore, older fathers give birth to offspring with longer telomeres21, and telomere length may, in itself, be related to childhood ALL risk22. However, increased paternal age has also been associated with increased rates of fetal loss, both spontaneous abortion and stillbirths18, this may imply that there is enhanced prenatal loss of infants at risk for leukemia or cancer conceived by older fathers, and raises the possibility of “live-birth bias”23.

As for birth weight, most research has focused on high birth weight as a risk factor for childhood leukemia, especially ALL. However Roman and colleagues24 have drawn attention to the paucity of childhood ALL cases among children with low birth weight. Whether these children are “protected “ from leukemia due to low somatic growth, or whether the low leukemia rates also reflect in utero loss of fetuses with poor growth characteristics and higher risks of leukemia is unclear. That older siblings may be further protected by having lower birth weight is intriguing, especially since they are at lower risk for impaired fetal growth. It is known that several types of neonatal infection are increased in low birth weight or small-for-gestational-age babies, and this increased risk may persist throughout childhood25. Infection may trigger preterm birth, itself a cause of low birth weight, however controlling for gestational age did not materially affect our results. Is it plausible that the enhanced “protection” conferred by lower birth weight in children with at least one older sibling is due to the compounding effect of increased early exposure to infectious agents, both in utero and post-partum, resulting in a broader immune repertoire? Ongoing studies in our consortium aim to identify DNA-based molecular signatures of infection and how they relate to childhood cancer. Once identified, these signatures may help determine to what extent the associations observed between birth order and leukemia are mediated by infection versus other mechanisms or other exposures.

The strengths of our study are the prospective nature of data collection spanning several countries and several decades. Birth weight, paternal age and birth order were ascertained in all cohorts in an unbiased fashion without reference to later cancer onset. Adjustment for multiple potential confounders did not substantially alter our findings nor did analysis by age of leukemia onset.

Our study is limited by relatively low numbers of events, with insufficient power to examine leukemia subtypes other than ALL. In the earlier cohorts misclassification of leukemia subtype may have occurred due to lack of immunophenotyping. Moreover, we had no information on immune or genetic subtypes of ALL, which may have distinct etiologies. We were not always able to distinguish previous live- from still-births. In some of the included cohorts, children have not all reached 15 years of age, so some findings may change when complete case ascertainment data become available. Further studies undertaken when all the cohorts have matured will provide more information on the entire spectrum of childhood leukemia through to adolescence as well as providing new opportunities for analyses within sibships, and regarding birth spacing.

In conclusion, we have found a clear protective association between having older siblings on childhood leukemia risk and two heretofore unreported possible effect modifiers. It is possible that recent large population-based registry studies reporting null or weak associations between birth order and leukemia9,10 did not discern the substantial effect reported herein because paternal age and birth weight were examined as covariates and not as potential modifiers. We look forward to efforts to determine whether our findings can be replicated in other populations. Additionally, it would be important to examine whether specific molecular or clinical subtypes of childhood leukemia are associated with these striking inverse relations.

Supplementary Material

1

Novelty and Impact:

Most studies of childhood leukemia (CL) are retrospective or registry-based. Using pooled, prospectively-collected data from six population-based birth cohorts we assessed associations between CL and birth order (proxy for pathogen exposure), exploring interactions with other birth and parental characteristics. We observed an inverse association between birth order and CL with effect modification by paternal age and birth weight . “Delayed infection” may provide a partial explanation for diminished CL risk in children with older siblings.

Funding:

This work was partly supported by the:

NIH (NCI, NICHD)- USA; National Children’s Study- USA;

Children’s Cancer Centre Foundation- Australia; Bluey Day Foundation- Australia; Baxter Family Foundation-Australia; The Rotary Club of North Brighton-Australia; Tour de Cure-Australia; Private philanthropic donations - Australia; Murdoch Children’s Research Institute (M1300049), Australia

Research Council of Norway through its Centres of Excellence funding scheme, project number 262700.

Trigon Foundation, Denmark

UK Medical Research Council and the Wellcome Trust (Grant ref: 092731) and the University of Bristol currently provide core support for ALSPAC.

Contributor Information

Ora Paltiel, Braun School of Public Health and Community Medicine and Dept of Hematology, Hadassah-Hebrew University..

Stanley Lemeshow, College of Public Health, The Ohio State University, Columbus, Ohio USA.

Gary S. Phillips, Statistical consultant, Department of Biomedical Informatics, The Ohio State University, Center for Biostatistics, Retired.

Gabriella Tikellis, Murdoch Children’s Research Institute, Royal Children’s Hospital, University of Melbourne, Melbourne, Australia..

Martha S. Linet, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland USA..

Anne-Louise Ponsonby, Murdoch Children’s Research Institute, Royal Childrens Hospital, University of Melbourne, Melbourne Australia..

Per Magnus, Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway..

Siri E. Håberg, Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway..

Sjurdur F Olsen, Centre for Fetal Programming, Dept Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark..

Charlotta Granström, Centre for Fetal Programming, Dept Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.

Mark Klebanoff, The Research Institute at Nationwide Children’s Hospital, Departments of Pediatrics, Obstetrics and Gynecology, and Epidemiology, The Ohio State University,700 Children’s Drive, WB 5321Columbus OH USA 43215..

Jean Golding, Centre for Child and Adolescent Health, University of Bristol, Bristol, UK..

Zdenko Herceg, Epigenetics Group, International Agency for Research on Cancer, Lyon, France..

Akram Ghantous, Epigenetics Group, International Agency for Research on Cancer, Lyon, France..

Jane Elizabeth Hirst, Nuffield Department of Obstetrics & Gynaecology, University of Oxford, Women’s Centre, John Radcliffe Hospital Oxford OX3 9 DU UK..

Arndt Borkhardt, Department of Pediatric Oncology, Hematology and Clinical Immunology, University Children’s Hospital, Medical Faculty, Heinrich Heine University Dusseldorf, Moorenstrasse 5, 40225, Dusseldorf.

Mary H. Ward, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland USA..

Signe Holst Søegaard, Dept of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark..

Terence Dwyer, The George Institute for Global Health, Nuffield Department of Obstetrics & Gynaecology, University of Oxford; Murdoch Children’s Research Institute, Royal Children’s Hospital, University of Melbourne, Melbourne, Australia..

References

  • 1.Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 2006;6(3):193–203. doi: 10.1038/nrc.1816. [DOI] [PubMed] [Google Scholar]
  • 2.Lin JN, Lin CL, Lin MC, Lai CH, Lin HH, Yang CH, Sung FC, Kao CH. Risk of leukaemia in children infected with enterovirus: A nationwide, retrospective, population-based, Taiwanese-registry, cohort study. Lancet Oncol 2015;16(13):1335–1343. doi: 10.1016/S1470-2045(15)00060-1. [DOI] [PubMed] [Google Scholar]
  • 3.Marcotte EL, Ritz B, Cockburn M, Yu F, Heck JE. Exposure to infections and risk of leukemia in young children. Cancer Epidemiol Biomarkers Prev 2014;23(7):1195–1203. doi: 10.1158/1055-9965.EPI-13-1330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Gradel KO, Kærlev L. Antibiotic use from conception to diagnosis of child leukaemia as compared to the background population: A nested case-control study. Pediatr Blood Cancer. 2015;62(7):1155–1161. doi: 10.1002/pbc.25477. [DOI] [PubMed] [Google Scholar]
  • 5.Rudant J, Orsi L, Menegaux F, Petit A, Baruchel A, Bertrand Y, Lambilliotte A, Robert A, Michel G, Margueritte G, Tandonnet J, Mechinaud F, Bordigoni P, Hémon D, Clavel J. Childhood acute leukemia, early common infections, and allergy: The ESCALE study. Am J Epidemiol 2010;172(9):1015–1027. doi: 10.1093/aje/kwq233. [DOI] [PubMed] [Google Scholar]
  • 6.Law GR. Host, family and community proxies for infections potentially associated with leukaemia. Radiat Prot Dosimetry. 2008;132(2):267–272. doi: 10.1093/rpd/ncn263. [DOI] [PubMed] [Google Scholar]
  • 7.MacMahon B, Newill VA. Birth characteristics of children dying of malignant neoplasms. J Natl Cancer Inst 1962;28(1):231–244. doi: 10.1093/jnci/28.1.231. [DOI] [PubMed] [Google Scholar]
  • 8.Von Behren J, Spector LG, Mueller BA, Carozza SE, Chow EJ, Fox EE, Horel S, Johnson KJ, McLaughlin C, Puumala SE, Ross JA, Reynolds P. Birth order and risk of childhood cancer: a pooled analysis from five US States. Int J Cancer. 2011;128(11):2709–2716. doi: 10.1002/ijc.25593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Schuz J, Luta G, Erdmann F, Ferro G, Bautz A, Simony SB, Dalton SO, Lightfoot T, Winther JF. Birth order and risk of childhood cancer in the Danish birth cohort of 1973–2010. Cancer Causes Control. 2015;26(11):1575–1582. doi: 10.1007/s10552-015-0651-z. [DOI] [PubMed] [Google Scholar]
  • 10.Crump C, Sundquist J, Sieh W, Winkleby MA, Sundquist K. Perinatal and familial risk factors for acute lymphoblastic leukemia in a Swedish national cohort. Cancer. 2015;121(7):1040–1047. doi: 10.1002/cncr.29172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Johnson W, Choh AC, Soloway LE, Czerwinski SA, Towne B, Demerath EW. Eighty-year trends in infant weight and length growth: The fels longitudinal study. J Pediatr 2012;160(5):762–768. doi: 10.1016/j.jpeds.2011.11.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Stykes J Fatherhood in the U.S.: Men’s Age at First Birth, 1987–2010 (FP- 11–04). National Center for Family & Marriage Research. 2011. [Google Scholar]
  • 13.Doing Better for Families- http://www.oecd.org/social/soc/doingbetterforfamilies.htm accessed 17/3/2018. 2011. doi: 10.1787/9789264098732-en. [DOI]
  • 14.Caughey RW, Michels KB. Birth weight and childhood leukemia: a meta-analysis and review of the current evidence. Int J Cancer. 2009;124(11):2658–2670. doi: 10.1002/ijc.24225. [DOI] [PubMed] [Google Scholar]
  • 15.Urhoj SK, Raaschou-Nielsen O, Hansen AV, Mortensen LH, Andersen PK, Nybo Andersen AM. Advanced paternal age and childhood cancer in offspring: A nationwide register-based cohort study. Int J Cancer. 2017;140(11):2461–2472. doi: 10.1002/ijc.30677. [DOI] [PubMed] [Google Scholar]
  • 16.Paltiel O, Tikellis G, Linet M, Golding J, Lemeshow S, Phillips G, Lamb K, Stoltenberg C, Håberg SE, Strøm M, Granstrøm C, Northstone K, Klebanoff M, Ponsonby AL, Milne E, Pedersen M, Kogevinas M, Ha E, Dwyer T. Birthweight and childhood cancer: Preliminary findings from the international childhood cancer cohort consortium (I4C). Paediatr Perinat Epidemiol 2015;29(4):335–345. doi: 10.1111/ppe.12193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kragh M, Larsen JM, Thysen AH, Rasmussen MA, Wolsk HM, Bisgaard H, Brix S. Divergent response profile in activated cord blood T cells from first-born child implies birth-order-associated in utero immune programming. Allergy Eur J Allergy Clin Immunol 2016;71(3):323–332. doi: 10.1111/all.12799. [DOI] [PubMed] [Google Scholar]
  • 18.Nybo Andersen A-M, Urhoj SK. Is advanced paternal age a health risk for the offspring? Fertil Steril 2017;107(2):312–318. doi: 10.1016/j.fertnstert.2016.12.019. [DOI] [PubMed] [Google Scholar]
  • 19.Oksuzyan S, Crespi CM, Cockburn M, Mezei G, Kheifets L. Birth weight and other perinatal characteristics and childhood leukemia in California. Cancer Epidemiol 2012;36(6). doi: 10.1016/j.canep.2012.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Yip BH, Pawitan Y, Czene K. Parental age and risk of childhood cancers: A population-based cohort study from Sweden. Int J Epidemiol 2006;35(6):1495–1503. doi: 10.1093/ije/dyl177. [DOI] [PubMed] [Google Scholar]
  • 21.Kimura M, Cherkas LF, Kato BS, Demissie S, Hjelmborg JB, Brimacombe M, Cupples A, Hunkin JL, Gardner JP, Lu X, Cao X, Sastrasinh M, Province MA, Hunt SC, Christensen K, Levy D, Spector TD, Aviv A. Offspring’s leukocyte telomere length, paternal age, and telomere elongation in sperm. PLoS Genet 2008;4(2):1–9. doi: 10.1371/journal.pgen.0040037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Sheng X, Zhang L, Luo D, Tong N, Wang M, Fang Y, Li J, Zhang Z. A common variant near TERC and telomere length are associated with susceptibility to childhood acute lymphoblastic leukemia in Chinese. Leuk Lymphoma 2012;53(9):1688–1692. doi: 10.3109/10428194.2012.671482. [DOI] [PubMed] [Google Scholar]
  • 23.Liew Z, Olsen J, Cui X, Ritz B, Arah OA. Bias from conditioning on live birth in pregnancy cohorts: An illustration based on neurodevelopment in children after prenatal exposure to organic pollutants. Int J Epidemiol 2015;44(1):345–354. doi: 10.1093/ije/dyu249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Roman E, Lightfoot T, Smith AG, Forman MR, Linet MS, Robison L, Simpson J, Kaatsch P, Grell K, Frederiksen K, Schüz J. Childhood acute lymphoblastic leukaemia and birthweight: Insights from a pooled analysis of case-control data from Germany, the United Kingdom and the United States. Eur J Cancer. 2013;49(6):1437–1447. doi: 10.1016/j.ejca.2012.11.017. [DOI] [PubMed] [Google Scholar]
  • 25.Miller JE, Hammond GC, Strunk T, Moore HC, Leonard H, Carter KW, Bhutta Z, Stanley F, de Klerk N, Burgner DP. Association of gestational age and growth measures at birth with infection-related admissions to hospital throughout childhood: a population-based, data-linkage study from Western Australia. Lancet Infect Dis 2016;16(8):952–961. doi: 10.1016/S1473-3099(16)00150-X. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES